Prebiotic Fructans on the Incidence of Acute Infectious Diseases in Children
Not Applicable
Completed
- Conditions
- Children, OnlyDiet ModificationInfectious Disease
- Registration Number
- NCT03241355
- Lead Sponsor
- Beneo-Institute
- Brief Summary
The study aims to explore whether prophylactic dietary supplementation with prebiotic inulin-type fructans is able to influence the intestinal microbiota and the frequency of infectious disease episodes in kindergarten children during a winter period.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 258
Inclusion Criteria
- Subject is healthy at the time of pre-examination
- Subject is aged 3-6 years at the time of pre-examination
- Subject attends a kindergarten at the time of pre-examination
Exclusion Criteria
- congenital disease or malformation influencing the gastrointestinal System
- children with congenital or acquired immunodeficiency
- children with food intolerance, food allergy or metabolic disorder requiring special diet
- children who regularly (more than 3 times per week) consumed products or food supplements containing prebiotics or probiotics
- children who consumed antibiotics or laxatives within 14 days
- children who had any infectious disease within 14 days at the time of pre-examination
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Frequency of infectious disease episodes 24 weeks period
- Secondary Outcome Measures
Name Time Method microbiota composition 24 weeks period fecal microbiota composition (qPCR, illumina)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms do prebiotic inulin-type fructans use to modulate intestinal microbiota in children?
How does prebiotic supplementation compare to standard-of-care in reducing acute infectious disease incidence in 3-6 year olds?
Which biomarkers correlate with response to prebiotic fructans in pediatric microbiota modulation?
What adverse events are associated with prebiotic inulin-type fructans in young children and how are they managed?
Are there combination therapies with prebiotic oligosaccharides that enhance microbiota composition for infectious disease prevention in children?